Investors Similar to Life Sciences at Goldman Sachs Alternatives
Discover 20 alternative investors with similar investment focus, venture_capital structure, and track record.
Target Investor
Life Sciences at Goldman Sachs Alternatives
Life Sciences at Goldman Sachs Alternatives is the life sciences investment arm of Goldman Sachs Asset Management, investing in innovative biopharmaceutical and medical technology companies through its alternatives platform. The group provides growth and late-stage capital to companies developing breakthrough therapies and healthcare technologies.
Similar Investors
Showing 20 results
About This Comparison
This alternatives page shows investors with similar characteristics to Life Sciences at Goldman Sachs Alternatives, including similar venture_capital structure, comparable investment focus, and track record. Use this page to discover alternative investors for your funding strategy, investor mapping, or competitive analysis.
Investors are ranked by total score, which reflects portfolio size, investment activity, and market presence on StartupHub.ai. Learn more about each investor by clicking their profile to see portfolio companies, investment rounds, and detailed information.
StartupHub.ai provides free access to investor profiles, funding data, and startup intelligence. No paywall, no enterprise subscription required.